• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Catellus Development

Catellus Development

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment

    Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment

  2. The VIX and Company Risk

    NO OFFER, INVESTMENT ADVICE, OR PERFORMANCE GUARANTEES All written content is for informational purposes only and may not constitute a complete description of available investment services or performance. Neither the information nor any opinion expressed constitutes an offer by IronHorse to buy or ...

  3. PIMCO's Kiesel: Management Change, but Fund Stays the Same

    Bill Gross' departure and the subsequent outflows have not changed the management process of PIMCO Total Return, says PIMCO's Mark Kiesel.

  4. Watch for Asset Bloat in These Bond-Fund Sectors

    Investors should be cautious of rapid inflows into high-yield and bank-loan funds as managers could have difficulty putting excess money to work in high-conviction ideas.

  5. Weapons of Mass Destruction?

    A great deal of misunderstanding surrounds the risks and opportunities of credit default swaps.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.